Acquired resistance to BRAFi reverses senescence-like phenotype in mutant BRAF melanoma.

Krayem M, Najem A, Journe F, Morandini R, Sales F, Awada A, Ghanem GE

Open source

DOI
10.18632/oncotarget.25879
Published
2018 Aug 7
Container
Oncotarget
Publisher
Not recorded
Open access
yes

Credibility signals

serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.18632/oncotarget.25879,
  title = {Acquired resistance to BRAFi reverses senescence-like phenotype in mutant BRAF melanoma.},
  author = {Krayem M and Najem A and Journe F and Morandini R and Sales F and Awada A and Ghanem GE},
  year = {2018},
  journal = {Oncotarget},
  doi = {10.18632/oncotarget.25879},
  url = {https://doi.org/10.18632/oncotarget.25879}
}

RIS

TY  - JOUR
TI  - Acquired resistance to BRAFi reverses senescence-like phenotype in mutant BRAF melanoma.
AU  - Krayem M
AU  - Najem A
AU  - Journe F
AU  - Morandini R
AU  - Sales F
AU  - Awada A
AU  - Ghanem GE
PY  - 2018
JO  - Oncotarget
DO  - 10.18632/oncotarget.25879
UR  - https://doi.org/10.18632/oncotarget.25879
ER  - 

APA

M, K., A, N., F, J., R, M., F, S., A, A., & GE, G. (2018). Acquired resistance to BRAFi reverses senescence-like phenotype in mutant BRAF melanoma.. Oncotarget. https://doi.org/10.18632/oncotarget.25879

Source records